$RIGL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in RIGEL PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in RIGEL PHARMACEUTICALS INC. Get notifications about new insider transactions in RIGEL PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 21.13 | 24,500 | 517,719 | 1,687,072 | 1.7 M to 1.7 M (-1.43 %) |
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 20.60 | 60,527 | 1,246,626 | 1,711,572 | 1.8 M to 1.7 M (-3.42 %) |
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 19.77 | 826 | 16,330 | 1,772,099 | 1.8 M to 1.8 M (-0.05 %) |
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 21.13 | 24,500 | 517,719 | 1,687,072 | 1.7 M to 1.7 M (-1.43 %) |
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 20.60 | 60,527 | 1,246,626 | 1,711,572 | 1.8 M to 1.7 M (-3.42 %) |
Sep 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 19.77 | 826 | 16,330 | 1,772,099 | 1.8 M to 1.8 M (-0.05 %) |
Sep 01 2004 | RIGL | RIGEL PHARMACEUTIC ... | RODRIGUEZ RAUL R | EVP, COO | Sell | S | 20.85 | 11,000 | 229,350 | 23,607 | 34.6 K to 23.6 K (-31.79 %) |
Aug 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Grant | A | 0.00 | 9,593 | 0 | 9,593 | 0 to 9.6 K |
Aug 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | D | 21.11 | 14,858 | 313,667 | 29,715 | 44.6 K to 29.7 K (-33.33 %) |
Aug 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | D | 21.11 | 403,892 | 8,526,564 | 807,784 | 1.2 M to 807.8 K (-33.33 %) |
Aug 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | D | 21.11 | 8,049 | 169,922 | 0 | 8 K to 0 (-100.00 %) |
Aug 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | D | 21.11 | 352,434 | 7,440,234 | 0 | 352.4 K to 0 (-100.00 %) |
Aug 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 21.84 | 27,499 | 600,619 | 1,772,099 | 1.8 M to 1.8 M (-1.53 %) |
Aug 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 21.77 | 5,000 | 108,847 | 1,799,598 | 1.8 M to 1.8 M (-0.28 %) |
Aug 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | Sell | D | 21.11 | 14,858 | 313,652 | 29,715 | 44.6 K to 29.7 K (-33.33 %) | |
Aug 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | Sell | D | 21.11 | 403,892 | 8,526,564 | 807,784 | 1.2 M to 807.8 K (-33.33 %) | |
Aug 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | Sell | D | 21.11 | 8,049 | 169,922 | 0 | 8 K to 0 (-100.00 %) | |
Aug 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | Sell | D | 21.11 | 352,434 | 7,440,234 | 0 | 352.4 K to 0 (-100.00 %) | |
Aug 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 21.92 | 922 | 20,214 | 0 | 922 to 0 (-100.00 %) |
Aug 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 21.84 | 27,499 | 600,619 | 1,772,099 | 1.8 M to 1.8 M (-1.53 %) |
Aug 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 21.77 | 5,000 | 108,847 | 1,799,598 | 1.8 M to 1.8 M (-0.28 %) |
Aug 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 21.84 | 27,499 | 600,619 | 1,772,925 | 1.8 M to 1.8 M (-1.53 %) |
Aug 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 21.77 | 5,000 | 108,847 | 1,800,424 | 1.8 M to 1.8 M (-0.28 %) |
Aug 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 21.84 | 27,499 | 600,619 | 1,772,925 | 1.8 M to 1.8 M (-1.53 %) |
Aug 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 21.77 | 5,000 | 108,847 | 1,800,424 | 1.8 M to 1.8 M (-0.28 %) |
Aug 23 2004 | RIGL | RIGEL PHARMACEUTIC ... | GOWER JAMES M | CEO & Board Chairma ... | Buy | J | 0.00 | 380 | 0 | 125,628 | 125.2 K to 125.6 K (+0.30 %) |
Aug 18 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 21.80 | 5,400 | 117,720 | 1,805,424 | 1.8 M to 1.8 M (-0.30 %) |
Aug 18 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 22.44 | 13,599 | 305,216 | 1,810,824 | 1.8 M to 1.8 M (-0.75 %) |
Aug 18 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 21.80 | 5,400 | 117,720 | 1,804,598 | 1.8 M to 1.8 M (-0.30 %) |
Aug 18 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 22.44 | 13,599 | 305,216 | 1,809,998 | 1.8 M to 1.8 M (-0.75 %) |
Aug 18 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 21.80 | 5,400 | 117,720 | 1,804,598 | 1.8 M to 1.8 M (-0.30 %) |
Aug 18 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 22.44 | 13,599 | 305,216 | 1,809,998 | 1.8 M to 1.8 M (-0.75 %) |
Aug 18 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 21.80 | 5,400 | 117,720 | 1,805,424 | 1.8 M to 1.8 M (-0.30 %) |
Aug 18 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 22.44 | 13,599 | 305,216 | 1,810,824 | 1.8 M to 1.8 M (-0.75 %) |
Aug 17 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 22.30 | 10,000 | 223,000 | 1,823,597 | 1.8 M to 1.8 M (-0.55 %) |
Aug 17 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 22.30 | 10,000 | 223,000 | 1,824,423 | 1.8 M to 1.8 M (-0.55 %) |
Aug 17 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 22.30 | 10,000 | 223,000 | 1,824,423 | 1.8 M to 1.8 M (-0.55 %) |
Aug 17 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 22.30 | 10,000 | 223,000 | 1,823,597 | 1.8 M to 1.8 M (-0.55 %) |
Aug 03 2004 | RIGL | RIGEL PHARMACEUTIC ... | STEINMETZ MICHAEL | 10% Owner | Sell | S | 18.68 | 1,968 | 36,762 | 1,833,597 | 1.8 M to 1.8 M (-0.11 %) |
Jul 16 2004 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Buy | P | 11.49 | 100 | 1,149 | 7,500 | 7.4 K to 7.5 K (+1.35 %) |
Jul 16 2004 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Buy | P | 11.47 | 1,600 | 18,352 | 7,400 | 5.8 K to 7.4 K (+27.59 %) |
Jul 16 2004 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Buy | P | 11.46 | 300 | 3,438 | 5,800 | 5.5 K to 5.8 K (+5.45 %) |
Jul 16 2004 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Buy | P | 11.45 | 300 | 3,436 | 5,500 | 5.2 K to 5.5 K (+5.77 %) |
Jul 16 2004 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Buy | P | 11.41 | 100 | 1,141 | 5,200 | 5.1 K to 5.2 K (+1.96 %) |
Jul 16 2004 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Buy | P | 11.40 | 100 | 1,140 | 5,100 | 5 K to 5.1 K (+2.00 %) |
Jul 07 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 14.88 | 7,847 | 116,786 | 1,833,597 | 1.8 M to 1.8 M (-0.43 %) |
Jul 07 2004 | RIGL | RIGEL PHARMACEUTIC ... | GALAKATOS NICHOLAS | 10% Owner | Sell | S | 15.33 | 1,652 | 25,325 | 1,833,597 | 1.8 M to 1.8 M (-0.09 %) |
Jul 07 2004 | RIGL | RIGEL PHARMACEUTIC ... | GADICKE ANSBERT | 10% Owner | Sell | J | 0.00 | 1,447 | 0 | 0 | 1.4 K to 0 (-100.00 %) |
Jul 07 2004 | RIGL | RIGEL PHARMACEUTIC ... | GADICKE ANSBERT | 10% Owner | Sell | S | 14.59 | 2,463 | 35,930 | 1,447 | 3.9 K to 1.4 K (-62.99 %) |
Jun 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Buy | J | 0.00 | 922 | 0 | 922 | 0 to 922 |
Jun 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | J | 0.00 | 1,499,989 | 0 | 1,833,597 | 3.3 M to 1.8 M (-45.00 %) |
Jun 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 15.83 | 2,877 | 45,545 | 3,333,586 | 3.3 M to 3.3 M (-0.09 %) |
Jun 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Buy | J | 0.00 | 1,569 | 0 | 1,569 | 0 to 1.6 K |
Jun 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | J | 0.00 | 1,499,989 | 0 | 1,833,597 | 3.3 M to 1.8 M (-45.00 %) |
Jun 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 15.83 | 2,877 | 45,545 | 3,333,586 | 3.3 M to 3.3 M (-0.09 %) |
Jun 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Buy | J | 0.00 | 16,203 | 0 | 1,849,800 | 1.8 M to 1.8 M (+0.88 %) |
Jun 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | J | 0.00 | 1,499,989 | 0 | 1,833,597 | 3.3 M to 1.8 M (-45.00 %) |
Jun 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 15.83 | 2,877 | 45,545 | 3,333,586 | 3.3 M to 3.3 M (-0.09 %) |
Jun 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Buy | J | 0.00 | 16,203 | 0 | 1,849,800 | 1.8 M to 1.8 M (+0.88 %) |
Jun 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | J | 0.00 | 1,499,989 | 0 | 1,833,597 | 3.3 M to 1.8 M (-45.00 %) |
Jun 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 15.83 | 2,877 | 45,545 | 3,333,586 | 3.3 M to 3.3 M (-0.09 %) |
Jun 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 15.80 | 54,500 | 861,182 | 3,336,463 | 3.4 M to 3.3 M (-1.61 %) |
Jun 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 15.54 | 69,807 | 1,084,850 | 3,390,963 | 3.5 M to 3.4 M (-2.02 %) |
Jun 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 15.80 | 54,500 | 861,182 | 3,336,463 | 3.4 M to 3.3 M (-1.61 %) |
Jun 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 15.54 | 69,807 | 1,084,850 | 3,390,963 | 3.5 M to 3.4 M (-2.02 %) |
Jun 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 15.80 | 54,500 | 861,182 | 3,336,463 | 3.4 M to 3.3 M (-1.61 %) |
Jun 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 15.54 | 69,807 | 1,084,850 | 3,390,963 | 3.5 M to 3.4 M (-2.02 %) |
Jun 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 15.80 | 54,500 | 861,182 | 3,336,463 | 3.4 M to 3.3 M (-1.61 %) |
Jun 28 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 15.54 | 69,807 | 1,084,850 | 3,390,963 | 3.5 M to 3.4 M (-2.02 %) |
Jun 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 15.50 | 388 | 6,014 | 3,460,770 | 3.5 M to 3.5 M (-0.01 %) |
Jun 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 15.51 | 29,805 | 462,153 | 3,461,158 | 3.5 M to 3.5 M (-0.85 %) |
Jun 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 15.50 | 388 | 6,014 | 3,460,770 | 3.5 M to 3.5 M (-0.01 %) |
Jun 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 15.51 | 29,805 | 462,153 | 3,461,158 | 3.5 M to 3.5 M (-0.85 %) |
Jun 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 15.50 | 388 | 6,014 | 3,460,770 | 3.5 M to 3.5 M (-0.01 %) |
Jun 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 15.51 | 29,805 | 462,153 | 3,461,158 | 3.5 M to 3.5 M (-0.85 %) |
Jun 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 15.50 | 388 | 6,014 | 3,460,770 | 3.5 M to 3.5 M (-0.01 %) |
Jun 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 15.51 | 29,805 | 462,153 | 3,461,158 | 3.5 M to 3.5 M (-0.85 %) |
Jun 14 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Option Exercise | A | 16.17 | 1,667 | 26,955 | 1,667 | |
Jun 14 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Option Exercise | A | 16.42 | 8,333 | 136,828 | 8,333 | |
Jun 14 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Option Exercise | A | 16.17 | 1,667 | 26,955 | 1,667 | |
Jun 14 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Option Exercise | A | 16.42 | 8,333 | 136,828 | 8,333 | |
Jun 14 2004 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Option Exercise | A | 16.17 | 1,667 | 26,955 | 1,667 | |
Jun 14 2004 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 16.17 | 1,667 | 26,955 | 1,667 | |
Jun 14 2004 | RIGL | RIGEL PHARMACEUTIC ... | RENTON HOLLINGS | Director | Option Exercise | A | 16.17 | 1,667 | 26,955 | 1,667 | |
Jun 14 2004 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Option Exercise | A | 16.17 | 1,667 | 26,955 | 1,667 | |
Jun 14 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Option Exercise | A | 16.17 | 1,667 | 26,955 | 1,667 | |
Jun 04 2004 | RIGL | RIGEL PHARMACEUTIC ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 17.66 | 8,333 | 147,161 | 8,333 | |
Jun 04 2004 | RIGL | RIGEL PHARMACEUTIC ... | MOOS WALTER H | Director | Option Exercise | A | 17.66 | 8,333 | 147,161 | 8,333 | |
Jun 04 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Option Exercise | A | 17.66 | 8,333 | 147,161 | 8,333 | |
Jun 04 2004 | RIGL | RIGEL PHARMACEUTIC ... | RODRIGUEZ RAUL R | V.P. Bus. Develop. ... | Option Exercise | A | 17.66 | 75,000 | 1,324,500 | 75,000 | |
Jun 04 2004 | RIGL | RIGEL PHARMACEUTIC ... | GROSSBARD ELLIOT B | Sr. VP Medical Deve ... | Option Exercise | A | 17.66 | 35,000 | 618,100 | 35,000 | |
Jun 04 2004 | RIGL | RIGEL PHARMACEUTIC ... | VANCE DOLLY | VP Intel. Prop.& Ge ... | Option Exercise | A | 17.66 | 45,000 | 794,700 | 45,000 | |
Jun 04 2004 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Option Exercise | A | 17.66 | 10,000 | 176,600 | 10,000 | |
Jun 04 2004 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Option Exercise | A | 17.66 | 8,333 | 147,161 | 8,333 | |
Jun 04 2004 | RIGL | RIGEL PHARMACEUTIC ... | RENTON HOLLINGS | Director | Option Exercise | A | 17.66 | 8,333 | 147,161 | 8,333 | |
Jun 04 2004 | RIGL | RIGEL PHARMACEUTIC ... | PAYAN DONALD G | Ex. VP Chief Sci. O ... | Option Exercise | A | 17.66 | 40,000 | 706,400 | 40,000 | |
Jun 04 2004 | RIGL | RIGEL PHARMACEUTIC ... | GOWER JAMES M | CEO & Board Chairma ... | Option Exercise | A | 17.66 | 80,000 | 1,412,800 | 80,000 | |
Jun 04 2004 | RIGL | RIGEL PHARMACEUTIC ... | WELCH JAMES H | CFO, VP & Secretary | Option Exercise | A | 17.66 | 30,000 | 529,800 | 30,000 | |
Jun 03 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 18.00 | 2,030 | 36,540 | 3,490,963 | 3.5 M to 3.5 M (-0.06 %) |
Jun 03 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 18.00 | 2,030 | 36,540 | 3,490,963 | 3.5 M to 3.5 M (-0.06 %) |
Jun 03 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 18.00 | 2,030 | 36,540 | 3,490,963 | 3.5 M to 3.5 M (-0.06 %) |
Jun 03 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 18.00 | 2,030 | 36,540 | 3,490,963 | 3.5 M to 3.5 M (-0.06 %) |
Jun 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 17.95 | 10,000 | 179,500 | 3,492,993 | 3.5 M to 3.5 M (-0.29 %) |
Jun 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 18.00 | 3,950 | 71,100 | 3,502,993 | 3.5 M to 3.5 M (-0.11 %) |
Jun 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 17.95 | 10,000 | 179,500 | 3,492,993 | 3.5 M to 3.5 M (-0.29 %) |
Jun 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 18.00 | 3,950 | 71,100 | 3,502,993 | 3.5 M to 3.5 M (-0.11 %) |
Jun 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 17.95 | 10,000 | 179,500 | 3,492,993 | 3.5 M to 3.5 M (-0.29 %) |
Jun 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 18.00 | 3,950 | 71,100 | 3,502,993 | 3.5 M to 3.5 M (-0.11 %) |
Jun 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 17.95 | 10,000 | 179,500 | 3,492,993 | 3.5 M to 3.5 M (-0.29 %) |
Jun 02 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 18.00 | 3,950 | 71,100 | 3,502,993 | 3.5 M to 3.5 M (-0.11 %) |
May 27 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 17.85 | 20,154 | 359,672 | 3,506,943 | 3.5 M to 3.5 M (-0.57 %) |
May 27 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 17.80 | 5,861 | 104,326 | 3,527,097 | 3.5 M to 3.5 M (-0.17 %) |
May 27 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 17.85 | 20,154 | 359,672 | 3,506,943 | 3.5 M to 3.5 M (-0.57 %) |
May 27 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 17.80 | 5,861 | 104,326 | 3,527,097 | 3.5 M to 3.5 M (-0.17 %) |
May 27 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 17.85 | 20,154 | 359,672 | 3,506,943 | 3.5 M to 3.5 M (-0.57 %) |
May 27 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 17.80 | 5,861 | 104,326 | 3,527,097 | 3.5 M to 3.5 M (-0.17 %) |
May 27 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 17.85 | 20,154 | 359,672 | 3,506,943 | 3.5 M to 3.5 M (-0.57 %) |
May 27 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 17.80 | 5,861 | 104,326 | 3,527,097 | 3.5 M to 3.5 M (-0.17 %) |
May 26 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 17.35 | 3,300 | 57,255 | 3,532,958 | 3.5 M to 3.5 M (-0.09 %) |
May 26 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 17.35 | 3,300 | 57,255 | 3,532,958 | 3.5 M to 3.5 M (-0.09 %) |
May 26 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 17.35 | 3,300 | 57,255 | 3,532,958 | 3.5 M to 3.5 M (-0.09 %) |
May 26 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 17.35 | 3,300 | 57,255 | 3,532,958 | 3.5 M to 3.5 M (-0.09 %) |
May 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Buy | P | 16.68 | 2,600 | 43,365 | 5,000 | 2.4 K to 5 K (+108.33 %) |
May 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Buy | P | 16.70 | 1,400 | 23,380 | 2,400 | 1,000 to 2.4 K (+140.00 %) |
May 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Buy | P | 16.66 | 100 | 1,666 | 1,000 | 900 to 1,000 (+11.11 %) |
May 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Buy | P | 16.65 | 100 | 1,665 | 900 | 800 to 900 (+12.50 %) |
May 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Buy | P | 16.59 | 100 | 1,659 | 800 | 700 to 800 (+14.29 %) |
May 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | COOPER ROBIN D G | Sr. V.P. Pharmaceut ... | Buy | P | 16.58 | 700 | 11,606 | 700 | 0 to 700 |
May 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Buy | J | 0.00 | 2,012 | 0 | 5,988 | 4 K to 6 K (+50.60 %) |
May 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Sell | J | 0.00 | 459,564 | 0 | 943,292 | 1.4 M to 943.3 K (-32.76 %) |
May 24 2004 | RIGL | RIGEL PHARMACEUTIC ... | FRAZIER ALAN D | Director | Sell | S | 17.61 | 2,333 | 41,082 | 0 | 2.3 K to 0 (-100.00 %) |
May 21 2004 | RIGL | RIGEL PHARMACEUTIC ... | EVNIN LUKE | 10% Owner | Sell | S | 17.25 | 139,313 | 2,402,857 | 3,536,258 | 3.7 M to 3.5 M (-3.79 %) |
May 21 2004 | RIGL | RIGEL PHARMACEUTIC ... | HENNER DENNIS | Director | Sell | S | 17.25 | 139,313 | 2,402,857 | 3,536,258 | 3.7 M to 3.5 M (-3.79 %) |
May 21 2004 | RIGL | RIGEL PHARMACEUTIC ... | SIMON NICHOLAS J III | Director | Sell | S | 17.25 | 139,313 | 2,402,857 | 3,536,258 | 3.7 M to 3.5 M (-3.79 %) |
May 21 2004 | RIGL | RIGEL PHARMACEUTIC ... | MPM BIOVENTURES III QP LP | 10% Owner | Sell | S | 17.25 | 139,313 | 2,402,857 | 3,536,258 | 3.7 M to 3.5 M (-3.79 %) |
May 10 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.50 | 69 | 1,484 | 8,050 | 8.1 K to 8.1 K (-0.85 %) |
May 10 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.50 | 3,031 | 65,167 | 352,434 | 355.5 K to 352.4 K (-0.85 %) |
May 10 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.50 | 69 | 1,484 | 8,050 | 8.1 K to 8.1 K (-0.85 %) |
May 10 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.50 | 3,031 | 65,167 | 352,434 | 355.5 K to 352.4 K (-0.85 %) |
May 04 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.31 | 2,126 | 45,298 | 8,119 | 10.2 K to 8.1 K (-20.75 %) |
May 04 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.31 | 93,074 | 1,983,100 | 355,465 | 448.5 K to 355.5 K (-20.75 %) |
May 04 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.31 | 2,126 | 45,298 | 8,119 | 10.2 K to 8.1 K (-20.75 %) |
May 04 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.31 | 93,074 | 1,983,100 | 355,465 | 448.5 K to 355.5 K (-20.75 %) |
Apr 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.25 | 188 | 3,995 | 10,245 | 10.4 K to 10.2 K (-1.80 %) |
Apr 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | ALTA PARTNERS II INC | 10% Owner | Sell | S | 21.25 | 8,212 | 174,505 | 448,539 | 456.8 K to 448.5 K (-1.80 %) |
Apr 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.25 | 188 | 3,995 | 10,245 | 10.4 K to 10.2 K (-1.80 %) |
Apr 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.25 | 8,212 | 174,505 | 448,539 | 456.8 K to 448.5 K (-1.80 %) |
Apr 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.25 | 777 | 16,512 | 10,433 | 11.2 K to 10.4 K (-6.93 %) |
Apr 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.25 | 34,023 | 723,002 | 456,751 | 490.8 K to 456.8 K (-6.93 %) |
Apr 30 2004 | RIGL | RIGEL PHARMACEUTIC ... | DELEAGE JEAN | Director | Sell | S | 21.25 | 179 | 3,804 | 11,210 | 11.4 K to 11.2 K (-1.57 %) |